ECHA shortlists 236 substances for scrutiny

EU Member States to examine 236 substances shortlisted in ECHA’s annual screening exercise for potential health and environmental risks; list not publicly available

ECHA prepares oxo- and microplastics restrictions

ECHA drafts restriction proposals for oxo-degradable plastics and microplastics to support European Commission’s plastics strategy

ECHA urged to share ‘strategic information’

ClientEarth report criticizes ECHA’s lack of transparency, requests more information on harmful chemicals in the EU, companies’ compliance, EU’s decision-making processes with regard to chemical safety

ECHA classifies BPA as environmental endocrine disruptor

ECHA adds 7 new SVHCs to Candidate List; entry for BPA updated to include endocrine disrupting properties with effects on environment

Restriction proposal for 6 PFASs

Swedish and German agencies propose restricting 6 per- and polyfluorinated substances, as well as mixtures and articles containing them; ECHA opens public consultation until June 20, 2018

BPA an environmental endocrine disruptor

ECHA’s Member States Committee supports Germany’s proposal to classify BPA as substance of very high concern (SVHC) due to endocrine disrupting properties with probable effects in the environment

DCHP and TMA identified as SVHCs

EU REACH Committee classifies dicyclohexyl phthalate and trimellitic anhydride as substances of very high concern; both substances relevant for food contact

Opinion: EDC guidance “doomed to fail”

PAN Europe criticizes draft guidance for identifying endocrine disruptors published by EFSA and ECHA; too much focus on mode of action of chemicals, precautionary principle overlooked, organization claims

RIVM critical of EU nano-observatory

Dutch institute for public health deems EU observatory for nanomaterials “limited in detailed information,” highlights importance of adapting REACH regulation for nanomaterials

Public consultation on draft EDC guidance

EFSA and ECHA publish draft guidance document on identification of endocrine disruptors; public consultation open until January 31, 2018